ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2015 American Transplant Congress

    Trajectory of Measured GFR Decades After Kidney Donation: Hyperfiltration Never Seems to End!

    H. Ibrahim, D. Berglund, R. Foley, A. Matas.

    U of MN, Mpls.

    While the effect of uninephrectomy on loss of GFR is a cardinal issue for potential kidney donors, current information relies on surrogates of unknown validity,…
  • 2015 American Transplant Congress

    The Role of Hemodialysis Social Networks in Transplantation: Five Year Follow Up of an Urban Hemodialysis Cohort

    A. Pai, A. Gillespie.

    Nephrology, Hypertension, and Kidney Transplantation, Temple University, Philadelphia, PA.

    Background: Racial and socioeconomic disparities are well known barriers to kidney transplantation (KT), especially among minority populations. Emerging evidence suggests social networks exist within hemodialysis…
  • 2015 American Transplant Congress

    Donor and Recipient Pretransplant Polyoma BK Serostatus: Relationship to BK-Viremia After Renal Transplantation

    H. Tseng, R. Lopez-Soler, N. Chandolias, T. Friedrich, J. Eldor, D. Conti.

    Surgery, Albany Medical College, Albany, NY.

    Background:Polyoma virus BK nephropathy is a serious complication after renal transplantation and is associated with a significant risk of graft loss and dysfunction. This study…
  • 2015 American Transplant Congress

    Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience

    P. Vaitla, U. Patel, A. Cruz, S. Guisti, A. Moiz, C.-S. Catherine, A. Cohen, G. Loss, H. Bohorquez, I. Carmody, T. Reichman, D. Bruce, S. Anders, J. Garces.

    Ochsner Clinic Foundation, New Orleans, LA.

    Background:Antibody induction therapy has been used for induction in up to 80% kidney transplant recipients according to United Network for Organ Sharing. It has been…
  • 2015 American Transplant Congress

    Analysis of the Temporal Evolution of Causes of Graft Loss Among Kidney Transplant Recipients in a US Southern State

    M. Kadian,1 M. Posadas Salas,1 M. Kamel,1 D. Taber,2 M. Salazar,1 P. Mohan,1 T. Srinivas.1

    1Department of Medicine, Medical University of South Carolina, Charleston, SC; 2Department of Surgery, Medical University of South Carolina, Charleston, SC.

    The past decade of kidney transplantation has seen many changes in immunosuppression (IS), donor, and recipient characteristics. This study analyzes the associations between the aforementioned…
  • 2015 American Transplant Congress

    Impact of Donor Age on Longterm Outcomes in Asian Kidney Transplant Recipients: A Multicenter Cohort Study

    K. Yoo,1 J. An,2 J.-H. Cho,3 C.-D. Kim,3 S.-K. Park,4 D.-W. Chae,5 Y. Oh,2 C. Lim,2 Y. Kim,1 Y. Kim,6 J. Lee.2

    1Internal Medicine, Seoul National University Hospital, Seoul, Korea; 2Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; 3Internal Medicine, Kyungpook National University Hospital, Daegu, Korea; 4Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; 5Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea; 6Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea.

    Background The living donor kidney transplantation (LDKT) is well known for best treatment of end-stage renal disease. Recently, kidney transplantation from elderly living donor has…
  • 2015 American Transplant Congress

    Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers

    D. Hoyer,1 A. Gallinat,1 T. Minor,2 F. Saner,1 P. Kocabayoglu,1 J. Treckmann,1 A. Paul.1

    1General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; 2Surgical Research Division, University Hospital Bonn, Bonn, Germany.

    Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…
  • 2015 American Transplant Congress

    The Impact of Perioperative Bleeding on Long-Term Outcomes of Mechanical Circulatory Support

    K. Lietz,1 M. Mooney,1 I. El Lakkis,2 C. Derber,2 U. Kelly,2 C. Wilson,2 A. Hoedt,1 P. Bourassa,1 B. Smith,1 M. McGrath,1 J. Herre.1

    1Sentara Norfolk General Hospital, Norfolk, VA; 2Eastern Virginia Medical School, Norfolk, VA.

    Purpose: Postoperative bleeding is a common complication of MCS surgery. The incidence of bleeding in published series exceeds by several times the 3-5% rates seen…
  • 2015 American Transplant Congress

    HLA-DR Matching Improves Immunologic Outcomes in Elderly Kidney Transplant Recipients

    F. Halleck, D. Khadzhynov, L. Liefeldt, P. Glander, J. Bamoulid, S. Kreimer, L. Lehner, K. Budde, O. Staeck.

    Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.

    BACKGROUND: The Eurotransplant senior program (ESP) neglects HLA matching for elderly (>65y) KTR. Only few data exist regarding the influence of HLA-DR-matching on immunologic outcomes.PATIENTS…
  • 2015 American Transplant Congress

    Safety and Efficacy of Pegylated Interferon and Ribavirin for Chronic Hepatitis C Following Renal Transplantation

    G. Chen, L. Zhu, S. Chen, X. Wang, Z. Lin.

    Institute of Organ Transplantation, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.

    Objective We sought to investigate the safety and efficacy of pegylated Interferon (PEG-IFN) and ribavirin for chronic hepatitis C (HCV) following renal transplantation.Methods Ten adult…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences